AstraZeneca COVID-19 vaccine causes very uncommon blood clots, EU regulator says


The COVID-19 vaccine made by AstraZeneca and the College of Oxford can typically trigger uncommon blood clots, accompanied by abnormally low platelets — the small blood cells concerned in clotting — in accordance with an investigation by the European Union’s European Medicines Company (EMA).

These uncommon blood clots and low platelet counts ought to be listed as attainable uncomfortable side effects of the vaccine, Emer Cooke, the EMA’s government director, said at a news conference April 7, in accordance with Science Journal correspondent Kai Kupferschmidt. Individuals receiving the photographs ought to stay conscious of those potential uncomfortable side effects, significantly inside the first two weeks of their vaccination, she stated, in accordance with CNN.


Please enter your comment!
Please enter your name here